Seattle, WA, United States of America

David Veesler

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: University of Washington. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Veesler. Retrieved from https://idiyas.com/inventor/david-veesler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Veesler: Inventor in Infection-Focused Biomedical Research

Introduction

David Veesler is an inventor based in Seattle, Washington, and is affiliated with the University of Washington. His patent work concerns polypeptides and nanoparticle-based compositions intended to treat or limit the development of infections.

Latest Patents

The supplied information identifies one patent associated with Veesler: “Polypeptides, compositions, and their use to treat or limit development of an infection.” The patent describes polypeptides with amino acid sequences at least 95% identical to specified sequences, nanoparticles containing those polypeptides, and compositions containing the nanoparticles. It also addresses using the nanoparticles or compositions to treat or limit the development of an infection. The reported total is 1 patent.

Career Highlights

Veesler’s listed patent reflects research directed toward potential infection-focused applications of polypeptides and nanoparticle formulations. His affiliation with the University of Washington connects this work to a university research setting.

Collaborations

The supplied information names Jing Yang Wang and Alexandra C. Walls as Veesler’s coworkers.

Conclusion

David Veesler’s reported patent work centers on polypeptides and nanoparticle compositions with potential applications in treating or limiting infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…